Sandra E. Dillahunt

Array ( [id] => 8465615 [patent_doc_number] => 20120270782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'FORMULATION FOR HGH AND RHIGF-1 COMBINATION' [patent_app_type] => utility [patent_app_number] => 13/513858 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10135 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212337 [patent_doc_number] => 20110135637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'TRIMODAL CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/947362 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13011 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135637.pdf [firstpage_image] =>[orig_patent_app_number] => 12947362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118574 [patent_doc_number] => 20110076247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'AGENT COMPRISING G-CSF FOR PREVENTION AND TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY' [patent_app_type] => utility [patent_app_number] => 12/915172 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4248 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076247.pdf [firstpage_image] =>[orig_patent_app_number] => 12915172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10621668 [patent_doc_number] => 09340605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => 'VHH for application in tissue repair, organ regeneration, organ replacement and tissue engineering' [patent_app_type] => utility [patent_app_number] => 13/503355 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 17652 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9950559 [patent_doc_number] => 08999342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Anti-fibroblast activation protein antibodies and methods and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/499718 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23910 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8416641 [patent_doc_number] => 20120244142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'ANTIBODY CAPABLE OF RECOGNIZING HLA CLASS I' [patent_app_type] => utility [patent_app_number] => 13/497545 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12244 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313050 [patent_doc_number] => 20120190044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE' [patent_app_type] => utility [patent_app_number] => 13/497514 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60339 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950103 [patent_doc_number] => 20130195883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'USE OF VAP-1 INHIBITORS FOR TREATING FIBROTIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 13/395029 [patent_app_country] => US [patent_app_date] => 2010-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10995 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9440315 [patent_doc_number] => 08709424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Anti-GITR antibodies' [patent_app_type] => utility [patent_app_number] => 13/388270 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22458 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335170 [patent_doc_number] => 20120201873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'CONTROLLED RELEASE FORMULATIONS OF LIPOCALIN MUTEINS' [patent_app_type] => utility [patent_app_number] => 13/388788 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19884 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482878 [patent_doc_number] => 20120282285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'MASP ISOFORMS AS INHIBITORS OF COMPLEMENT ACTIVATION' [patent_app_type] => utility [patent_app_number] => 13/383676 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 28053 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8174441 [patent_doc_number] => 20120108947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'METHOD FOR PREDICTING WEIGHT GAIN ASSOCIATED WITH A PHARMACEUTICAL THERAPY' [patent_app_type] => utility [patent_app_number] => 13/382532 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8662 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108947.pdf [firstpage_image] =>[orig_patent_app_number] => 13382532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382499 [patent_doc_number] => 20120226119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'VIVO TUMOR VASCULATURE IMAGING' [patent_app_type] => utility [patent_app_number] => 13/383197 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25784 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289342 [patent_doc_number] => 20120177668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'IMMUNOMODULATING COMPOSITIONS COMPRISING INTERLEUKIN 13 INHIBITORS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/381757 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 33052 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277342 [patent_doc_number] => 20120171221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'BIOMARKERS FOR THE EARLY DETECTION OF AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/382286 [patent_app_country] => US [patent_app_date] => 2010-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 25545 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138425 [patent_doc_number] => 20120093765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'PROCESS FOR PURIFICATION OF RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTOR' [patent_app_type] => utility [patent_app_number] => 13/378973 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5733 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093765.pdf [firstpage_image] =>[orig_patent_app_number] => 13378973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427630 [patent_doc_number] => 08703705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Modified factor VIII peptides' [patent_app_type] => utility [patent_app_number] => 13/320201 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 12 [patent_no_of_words] => 10997 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776214 [patent_doc_number] => 20120039844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'COMPOSITION AND USE OF N-ALPHA-METHYLHISTAMINE DIHYDROCHLORIDE FOR THE REDUCTION OF OXYGEN RADICAL FORMATION' [patent_app_type] => utility [patent_app_number] => 13/264321 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10914 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039844.pdf [firstpage_image] =>[orig_patent_app_number] => 13264321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8266078 [patent_doc_number] => 20120165508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'FUSION PROTEINS THE PROCESS TO PREPARATION AND UTILIZATION IN EXPRESSION SYSTEMS OF RECOMBINANT PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/144493 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7856 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651811 [patent_doc_number] => 20110301080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/133976 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12737 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301080.pdf [firstpage_image] =>[orig_patent_app_number] => 13133976 [rel_patent_id] =>[rel_patent_doc_number] =>)